U.S. Pharma Stock News

Phillips Edison (PECO) is making headlines this week after topping earnings estimates for the third quarter and boosting its full-year 2025 earnings guidance. This signals continued confidence in its business model. See our latest analysis for Phillips Edison. The upbeat third quarter and full-year guidance bump have sparked some optimism around Phillips Edison, but the share price has not quite matched the momentum yet. Over the past year, total shareholder return is down 2.2%, even as...

Gevo is pausing its billion-dollar alcohol-to-jet fuel project in Lake Preston, South Dakota and shifting operations to North Dakota after securing approval to amend its federal loan terms. The move reflects both regulatory and economic considerations. See our latest analysis for Gevo. Gevo’s recent decision to relocate major project efforts comes after a period of notable share price momentum, with a 79% surge over the past three months and a sharp 20% one-month gain. Despite these strong...

Amphenol (NYSE:APH) shares climbed after the company delivered impressive third-quarter earnings, lifting both revenue and profit significantly compared to last year. Management also raised its outlook and increased the quarterly dividend by 52%. See our latest analysis for Amphenol. Amphenol’s remarkable momentum really stands out this year. Following robust Q3 results, a major dividend boost, and steady share buybacks, the company’s 1-year total shareholder return is a staggering 96%, with...

Natera recently reported results from the phase 3 IMvigor011 trial, showing its Signatera test can enhance treatment selection and improve both disease-free and overall survival in muscle-invasive bladder cancer; these findings were presented at the European Society for Medical Oncology Congress. A key insight is that this data supports Natera's pursuit of FDA premarket approval for Signatera as a companion diagnostic, potentially expanding its clinical and commercial reach in...

Coeur Mining (NYSE:CDE) shares dropped as gold and silver prices slid, setting the stage for investor focus on its upcoming third quarter earnings report due October 29. That announcement will coincide with the Federal Reserve’s interest rate decision. See our latest analysis for Coeur Mining. While Coeur Mining’s 1-day share price return slipped 1.7% following weaker bullion prices, the big picture shows powerful momentum, with the share price up 201% year-to-date and a remarkable 176.7%...

NCR Voyix (VYX) just secured a major win, landing a deal to become the preferred technology provider for Marco’s Pizza as the fast-growing chain ramps up its international expansion. The first store is set to launch in Mexico later this year, with more locations to follow. See our latest analysis for NCR Voyix. Momentum has been hard to come by for NCR Voyix over the past year. The latest share price closed at $11.80 and the 1-year total shareholder return sits at -9.9%. While news of...

Revvity, Inc. released its third-quarter results, revised full-year revenue guidance to US$2.83 billion–US$2.88 billion due to currency fluctuations, reaffirmed its organic growth outlook, and announced a US$1 billion share repurchase program valid for two years. Anita Gonzales was appointed as Vice President and Chief Accounting Officer, reflecting an emphasis on experienced financial leadership, while the company also declared a regular quarterly dividend of US$0.07 per share. We’ll...

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

Earlier this week, RBC Capital initiated coverage on Array Digital Infrastructure, now exclusively focused on US tower operations after divesting its UScellular wireless business. The firm is anticipated to begin regular dividend payments after the closure of pending spectrum transactions, with near-term colocation opportunities adding further potential. We'll consider how the analyst’s positive outlook, centered on Array Digital's new tower-focused strategy, influences the company's...

PennyMac Mortgage Investment Trust (PMT) just released its third quarter earnings, reporting strong year-over-year gains in net income and earnings per share. The results highlight clear progress in the company’s operating performance. See our latest analysis for PennyMac Mortgage Investment Trust. PennyMac Mortgage Investment Trust has built some positive momentum following its third quarter results, with a 6.6% share price gain over the past week and a 4.8% total shareholder return in the...

10x Genomics (TXG) is partnering with Anthropic to integrate its single cell and spatial biology analysis tools into Claude for Life Sciences. This move allows researchers to access advanced workflows through natural language, making complex data analysis more approachable. See our latest analysis for 10x Genomics. After a tough stretch, 10x Genomics is showing signs of renewed interest. The stock has rebounded with a 17.5% one-month share price return following news of partnerships with...

Valmont Industries recently reported third-quarter earnings, achieving US$1.05 billion in sales and US$99.03 million in net income, with a 21.2% rise in diluted earnings per share year over year. This performance was driven by strength in the Infrastructure segment, leading the company to raise its full-year earnings guidance and reinforcing confidence from market analysts. Given the raised full-year guidance, we'll explore how this improved outlook could influence Valmont Industries’...

Gilat Satellite Networks Ltd. recently announced that its Commercial Division secured US$42 million in orders from a leading satellite operator, focused on its multi-orbit SkyEdge IV platform, with delivery scheduled over the next 12 months. This commitment is set to expand the global presence of SkyEdge IV, which is increasingly pivotal as satellite operators aim to provide next-generation connectivity for applications such as in-flight connectivity and enterprise broadband. We'll explore...

On October 17, 2025, Regeneron Pharmaceuticals announced that the European Medicines Agency's Committee for Medicinal Products for Human Use adopted a positive opinion for Libtayo as an adjuvant treatment for adults with cutaneous squamous cell carcinoma at high risk of recurrence after surgery and radiation. This regulatory milestone, which closely follows recent FDA approval and is backed by robust Phase 3 trial data, highlights growing international momentum behind Libtayo’s expansion in...

Vulcan Materials (VMC) has seen its stock deliver double-digit gains so far this year, rising 15% on a total return basis. Investors have been tracking its recent performance and weighing how these returns compare with the company's longer-term trends. See our latest analysis for Vulcan Materials. Vulcan Materials' share price momentum has cooled a bit over the past month, but its year-to-date price return of 14.54% suggests market optimism is holding up. Looking further back, the company...

Agios Pharmaceuticals (AGIO) shares are in focus after the company announced that the European Medicines Agency's committee adopted a positive opinion for PYRUKYND, its oral treatment for thalassemia-linked anemia. This milestone brings PYRUKYND closer to potential approval in Europe. See our latest analysis for Agios Pharmaceuticals. Momentum has returned for Agios Pharmaceuticals, with the recent positive regulatory news helping drive the share price up 11.3% over the past month and...

Dynatrace (DT) shares drew attention after the company and ServiceNow announced a multi-year strategic partnership. The collaboration integrates their AI and automation platforms to help enterprise customers improve IT operations and incident management. See our latest analysis for Dynatrace. While Dynatrace’s high-profile partnership with ServiceNow has put a spotlight on the company, its recent 1-year total shareholder return of -7.2% suggests investors are still weighing the pace of growth...

Donnelley Financial Solutions (DFIN) just wrapped up the termination of its main defined benefit pension plan, a move that has been years in the making. By winding down the plan, DFIN has cleared a significant liability from its balance sheet and strengthened its financial outlook. See our latest analysis for Donnelley Financial Solutions. DFIN’s move to eliminate its pension liability arrives just as the stock has been working through a volatile stretch. Its share price slipped more than 17%...

Burford Capital recently provided an update on the ongoing YPF litigation, announcing that oral arguments for the Main Appeal against Argentina took place on October 29, 2025, with recognition and enforcement proceedings also advancing across multiple foreign jurisdictions as Argentina continues to contest the process. This development introduces ongoing legal uncertainty and the potential for substantial future impacts on Burford's operations and stakeholder outcomes, given the scale of the...

Renasant (RNST) shares have edged higher in recent sessions, with investors showing mild interest despite a lack of headline-grabbing developments. The current price trend invites a closer look at underlying performance and valuation. See our latest analysis for Renasant. Renasant’s share price has slipped about 6% over the past month but remains down only modestly for the year. Recent trading reflects a balancing act between investor caution and confidence in the bank’s fundamentals...

Grand Canyon Education (LOPE) recently announced that Kathy J. Claypatch has resigned from her role as Chief Information Officer. For investors, leadership transitions in key operational areas often invite fresh attention to the company’s direction and digital strategy. See our latest analysis for Grand Canyon Education. Even with some changes in leadership, Grand Canyon Education's shares have climbed in recent months. The company notched a 29.8% share price return in the past quarter and...

Clearwater Analytics Holdings (CWAN) just launched a new integration with J.P. Morgan Asset Management, connecting Enfusion by Clearwater to the Morgan Money trading platform. This move streamlines the process by which hedge funds invest and manage idle cash. See our latest analysis for Clearwater Analytics Holdings. Despite rolling out new solutions like the J.P. Morgan integration to expand its reach, Clearwater Analytics Holdings has seen its momentum stall, with a year-to-date share price...

On October 21, 2025, CareTrust REIT's Board expanded from five to six directors and appointed Gregory K. Stapley, former CEO and founder, to rejoin the Board effective January 1, 2026, without committee assignments. Mr. Stapley’s return brings deep institutional knowledge and signals renewed leadership continuity, reflecting ongoing investment in talent and sector expertise at a pivotal time for the company. We'll examine how the addition of Mr. Stapley may influence CareTrust's approach to...

Insperity, Inc.'s ( NYSE:NSP ) price-to-sales (or "P/S") ratio of 0.3x might make it look like a buy right now compared...